# The Effects of Ultrasound Guided Ozone and Lidocaine Injections in Piriformis Syndrome

> **NCT06130618** · NA · UNKNOWN · sponsor: **Ankara City Hospital Bilkent** · enrollment: 28 (estimated)

## Conditions studied

- Piriformis Syndrome

## Interventions

- **OTHER:** Ozone
- **DRUG:** Lidocain

## Key facts

- **NCT ID:** NCT06130618
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06130618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06130618, "The Effects of Ultrasound Guided Ozone and Lidocaine Injections in Piriformis Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06130618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*